UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models

Cancer gene therapy, 2011-12, Vol.18 (12), p.871-883

2011

Volltextzugriff (PDF)

Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer

Cancer gene therapy, 2013-11, Vol.20 (11), p.642-649

2013

Volltextzugriff (PDF)

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

Human gene therapy, 2001-11, Vol.12 (16), p.1955-1967

2001

Volltextzugriff (PDF)

Histologic and immunohistochemical analysis of tissue response to adenovirus‐mediated herpes simplex thymidine kinase gene therapy of ovarian cancer

International journal of gynecological cancer, 2002-01, Vol.12 (1), p.66-73

2002

Volltextzugriff (PDF)

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters

Prostate cancer and prostatic diseases, 2002-12, Vol.5 (4), p.316-325

2002

Volltextzugriff (PDF)

In situ gene therapy for adenocarcinoma of the prostate : A phase I clinical trial

Human gene therapy, 1999-05, Vol.10 (7), p.1239-1249

1999

Volltextzugriff (PDF)

Administration of Helper-Dependent Adenoviral Vectors and Sequential Delivery of Different Vector Serotype for Long-Term Liver-Directed Gene Transfer in Baboons

Proceedings of the National Academy of Sciences - PNAS, 1999-10, Vol.96 (22), p.12816-12821

1999

Volltextzugriff (PDF)

Phase I Study of Adenoviral Delivery of the HSV-tk Gene and Ganciclovir Administration in Patients with Recurrent Malignant Brain Tumors

Molecular therapy, 2000-02, Vol.1 (2), p.195-203

2000

Volltextzugriff (PDF)

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein‐Barr virus–positive Hodgkin's lymphoma

International journal of cancer, 2001-09, Vol.93 (5), p.706-713

2001

Volltextzugriff (PDF)

Liver Cirrhosis Is Reverted by Urokinase-Type Plasminogen Activator Gene Therapy

Molecular therapy, 2000-12, Vol.2 (6), p.545-551

2000

Volltextzugriff (PDF)

SUICIDE GENE THERAPY TOXICITY AFTER MULTIPLE AND REPEAT INJECTIONS IN PATIENTS WITH LOCALIZED PROSTATE CANCER

The Journal of urology, 2000-06, Vol.163 (6), p.1747-1750

2000

Volltextzugriff (PDF)

Multiplicity of Infection/Multiplicity of Confusion

Molecular therapy, 2000-11, Vol.2 (5), p.420-421

2000

Volltextzugriff (PDF)

Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data

International journal of radiation oncology, biology, physics, 2004-04, Vol.58 (5), p.1520-1529

2004

Volltextzugriff (PDF)

Impact of Preimmunization on Adenoviral Vector Expression and Toxicity in a Subcutaneous Mouse Cancer Model

Molecular therapy, 2002-09, Vol.6 (3), p.342-348

2002

Volltextzugriff (PDF)

Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment

Anticancer research, 1999-05, Vol.19 (3B), p.2163

1999

Volltextzugriff (PDF)

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer : A preliminary report

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.605-613

2001

Volltextzugriff (PDF)

Evolution of a gene therapy clinical trial. From bench to bedside and back

Journal of neuro-oncology, 2003-12, Vol.65 (3), p.307

2003

Volltextzugriff (PDF)

Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer

Molecular therapy, 2001-04, Vol.3 (4), p.536-542

2001

Volltextzugriff (PDF)

Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression

Cancer gene therapy, 2001-03, Vol.8 (3), p.168-175

2001

Volltextzugriff (PDF)

Improved Effects of Viral Gene Delivery of Human uPA plus Biliodigestive Anastomosis Induce Recovery from Experimental Biliary Cirrhosis

Molecular therapy, 2004-01, Vol.9 (1), p.30-37

2004

Volltextzugriff (PDF)

Combining Radiotherapy with Gene Therapy (From the Bench to the Bedside): A Novel Treatment Strategy for Prostate Cancer

The oncologist (Dayton, Ohio), 2002-01, Vol.7 (5), p.458-466

2002

Volltextzugriff (PDF)

Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer

Cancer gene therapy, 2000-06, Vol.7 (6), p.839-844

2000

Volltextzugriff (PDF)

Working Toward an Adenoviral Vector Testing Standard

Molecular therapy, 2000-12, Vol.2 (6), p.532-534

2000

Volltextzugriff (PDF)

Gene Therapy Coming of Age in Latin America

Molecular therapy, 2002-08, Vol.6 (2), p.153-154

2002

Volltextzugriff (PDF)

Hepatocyte Gene Therapy in a Large Animal: A Neonatal Bovine Model of Citrullinemia

Proceedings of the National Academy of Sciences - PNAS, 1999-03, Vol.96 (7), p.3981-3986

1999

Volltextzugriff (PDF)

1 – 25 von 42

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieGene Therapy

ThemaGene Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)

Erscheinungsjahr

n.n

Thema

Science & Technology
(35)
Life Sciences & Biomedicine
(33)
Humans
(30)
Thymidine Kinase - Genetics
(21)
Adenoviridae - Genetics
(20)
Oncology
(19)
Biotechnology & Applied Microbiology
(18)
Genetics & Heredity
(18)
Male
(18)
Medicine, Research & Experimental
(18)
Research & Experimental Medicine
(18)
Animals
(16)
Genetic Therapy - Methods
(15)
Prostatic Neoplasms - Therapy
(15)
Genetic Vectors
(14)
Prostate Cancer
(14)
Adenovirus
(13)
Adenoviruses
(13)
Antiviral Agents - Therapeutic Use
(12)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma models

Intraprostatic distribution and long-term follow-up after AdV-tk immunotherapy as neoadjuvant to surgery in patients with prostate cancer

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

Histologic and immunohistochemical analysis of tissue response to adenovirus‐mediated herpes simplex thymidine kinase gene therapy of ovarian cancer

Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters

In situ gene therapy for adenocarcinoma of the prostate : A phase I clinical trial

Administration of Helper-Dependent Adenoviral Vectors and Sequential Delivery of Different Vector Serotype for Long-Term Liver-Directed Gene Transfer in Baboons

Phase I Study of Adenoviral Delivery of the HSV-tk Gene and Ganciclovir Administration in Patients with Recurrent Malignant Brain Tumors

Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen: A potential treatment strategy for Epstein‐Barr virus–positive Hodgkin's lymphoma

Liver Cirrhosis Is Reverted by Urokinase-Type Plasminogen Activator Gene Therapy

SUICIDE GENE THERAPY TOXICITY AFTER MULTIPLE AND REPEAT INJECTIONS IN PATIENTS WITH LOCALIZED PROSTATE CANCER

Multiplicity of Infection/Multiplicity of Confusion

Phase I–II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer—interim report on PSA response and biopsy data

Impact of Preimmunization on Adenoviral Vector Expression and Toxicity in a Subcutaneous Mouse Cancer Model

Thymidine kinase (TK) gene therapy of solid tumors: valacyclovir facilitates outpatient treatment

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer : A preliminary report

Evolution of a gene therapy clinical trial. From bench to bedside and back

Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer

Coxsackievirus-adenovirus receptor expression in ovarian cancer cell lines is associated with increased adenovirus transduction efficiency and transgene expression

Improved Effects of Viral Gene Delivery of Human uPA plus Biliodigestive Anastomosis Induce Recovery from Experimental Biliary Cirrhosis

Combining Radiotherapy with Gene Therapy (From the Bench to the Bedside): A Novel Treatment Strategy for Prostate Cancer

Thymidine kinase gene therapy with concomitant topotecan chemotherapy for recurrent ovarian cancer

Working Toward an Adenoviral Vector Testing Standard

Gene Therapy Coming of Age in Latin America

Hepatocyte Gene Therapy in a Large Animal: A Neonatal Bovine Model of Citrullinemia

Aktive Filter

Suchergebnisse filtern